| After 3 months | After 6 months | ||
---|---|---|---|---|
Observed changes | Adjusted changes | Observed changes | Adjusted changes | |
QLQ-C30 | ||||
 Global Health Status | 16 | 12a | 0.5 | 8a |
 Physical functioning | 12 | 12a | 0.4 | 9a |
 Role functioning | 26 | 19a | 2 | 18a |
 Cognitive functioning | 5 | 11a | 1 | 10a |
 Social functioning | 20 | 15a | 1 | 10a |
 Emotional functioning | 3.5 | 6a | 0.5 | 6a |
 Fatigue | 27 | 23a | 0.2 | 20a |
 Pain | 14 | 9a | 2 | 17a |
 Dyspnea | 9 | 11a | 4 | 8a |
 Insomnia | 6 | 8a | 4 | 15a |
 Financial difficulties | 10 | 8a | 3 | 5a |
 Appetite loss | 10 | 11a | 10 | 4 |
 Constipation | 15 | 10a | 1 | 3 |
 Nausea and vomiting | 9 | 8a | 3 | 1 |
QLQ-BR23 | ||||
 Body image | 20 | 15a | 0.4 | 11a |
 Sexual functioning | 7 | 7a | 0.4 | 11a |
 Systemic therapy side effects | 19 | 20a | 3 | 10a |
 Breast symptoms | 14 | 18a | 4 | 6a |
 Arm symptoms | 8 | 9a | 0.6 | 11a |
 Sexual enjoyment | 14 | 12a | 13 | 15a |
 Future perspectives | 7 | 9a | 3 | 0.7 |